LUNESTA

sumitomo pharma canada, inc.🇨🇦 Health Canada

Approval Id: 943ed946292f4435
Drug Approval Canada Name: LUNESTA
Product Name: LUNESTA
Status: Marketed
Status Date: 2024-04-18
Original Market Date: 2020-10-20
Din: 02453215
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 28:24.92
Atc Original: N05CF04 ESZOPICLONE
Atc Name: n 05 cf 04
Aig Number: 0157971002
Company Name: sumitomo pharma canada, inc.
Company Address: 301, 7025 Langer Drive, Mississauga, Ontario, Canada, L5N 0E8

ESZOPICLONE

2 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

943ed946292f4435

Type

Standard